Login / Signup

The V 2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells.

G MarronciniC AnceschiL NaldiB FibbiF BaldanziM MaggiAlessandro Peri
Published in: Journal of endocrinological investigation (2022)
receptor might be considered a possible target in anti-cancer strategies in the future.
Keyphrases
  • endothelial cells
  • signaling pathway
  • induced pluripotent stem cells
  • current status
  • pluripotent stem cells
  • binding protein
  • polycystic kidney disease